000 | 01204 a2200313 4500 | ||
---|---|---|---|
005 | 20250513171556.0 | ||
264 | 0 | _c19990420 | |
008 | 199904s 0 0 eng d | ||
022 | _a0014-5793 | ||
024 | 7 |
_a10.1016/s0014-5793(99)00236-7 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDomínguez-Jiménez, C | |
245 | 0 | 0 |
_aPrevention of alphaII(b)beta3 activation by non-steroidal antiinflammatory drugs. _h[electronic resource] |
260 |
_bFEBS letters _cMar 1999 |
||
300 |
_a318-22 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xpharmacology |
650 | 0 | 4 |
_aBlood Platelets _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xpharmacology |
650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xmetabolism |
700 | 1 | _aDíaz-González, F | |
700 | 1 | _aGonzález-Alvaro, I | |
700 | 1 | _aCesar, J M | |
700 | 1 | _aSánchez-Madrid, F | |
773 | 0 |
_tFEBS letters _gvol. 446 _gno. 2-3 _gp. 318-22 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0014-5793(99)00236-7 _zAvailable from publisher's website |
999 |
_c10060493 _d10060493 |